Following ischemic stroke (IS), patients treated with anticoagulant therapy often have cerebral microbleeds (CMBs). Researchers at the Department of Neurology and Stroke Center, University of Basel, Switzerland, have shown that the frequency of CMBs may be related to the type of anticoagulant used and that they may be associated with negative outcomes.
Following ischemic stroke, cerebral microbleeds are associated with unfavorable outcomes
Ology Medical Education is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.
No responsibility is assumed by Ology Medical Education for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, Ology Medical Education recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of Ology Medical Education or the sponsor. Ology Medical Education assumes no liability for any material contained herein.